Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Goldwasser

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
ASAIO Transactions|July 1, 1989
Fall of cholesterol with time on dialysis: impact on atherogenicityM Lapuz, M M Avram, A Lustig, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1989
Variability of peritoneal clearances for apolipoprotein and its relationship to susceptibility for atherosclerotic changes in CAPDP A Fein, D Fletcher, A Antignani, et al.
Journal of the American Society of Nephrology : JASN|March 1, 1993
Predictors of mortality in hemodialysis patientsP Goldwasser, N Mittman, A Antignani, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 1993
Prealbumin and lipoprotein(a) in hemodialysis: relationships with patient and vascular access survivalP Goldwasser, M A Michel, J Collier, et al.
American Journal of Nephrology|January 1, 1990
Urinary red cell size: diagnostic value and determinantsP Goldwasser, A Antignani, N Mittman, et al.
ASAIO Transactions|July 1, 1988
Lipids in diabetic and nondiabetic hemodialysis and CAPD patientsM M Avram, A Antignani, P Goldwasser, et al.
New York State Journal of Medicine|May 1, 1991
Lipid abnormalities in black renal patientsD E Burrell, A Antignani, P Goldwasser, et al.
The American Journal of Medicine|November 1, 1989
Cholesterol and lipid disturbances in renal disease: the natural history of uremic dyslipidemia and the impact of hemodialysis and continuous ambulatory peritoneal dialysisM M Avram, P A Fein, A Antignani, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
ASAIO Transactions|July 1, 1989
Fall of cholesterol with time on dialysis: impact on atherogenicityM Lapuz, M M Avram, A Lustig, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1989
Variability of peritoneal clearances for apolipoprotein and its relationship to susceptibility for atherosclerotic changes in CAPDP A Fein, D Fletcher, A Antignani, et al.
Journal of the American Society of Nephrology : JASN|March 1, 1993
Predictors of mortality in hemodialysis patientsP Goldwasser, N Mittman, A Antignani, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 1993
Prealbumin and lipoprotein(a) in hemodialysis: relationships with patient and vascular access survivalP Goldwasser, M A Michel, J Collier, et al.
American Journal of Nephrology|January 1, 1990
Urinary red cell size: diagnostic value and determinantsP Goldwasser, A Antignani, N Mittman, et al.
ASAIO Transactions|July 1, 1988
Lipids in diabetic and nondiabetic hemodialysis and CAPD patientsM M Avram, A Antignani, P Goldwasser, et al.
New York State Journal of Medicine|May 1, 1991
Lipid abnormalities in black renal patientsD E Burrell, A Antignani, P Goldwasser, et al.
The American Journal of Medicine|November 1, 1989
Cholesterol and lipid disturbances in renal disease: the natural history of uremic dyslipidemia and the impact of hemodialysis and continuous ambulatory peritoneal dialysisM M Avram, P A Fein, A Antignani, et al.
Pageof 3